Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

ORAL-PROTECT I: Oral Asepsis Preventing Transmission During Intubation (ORAL-PROTECT I)

21 giugno 2026 aggiornato da: Manfred Blobner, University Hospital Ulm

ORAL-PROTECT I: Oral Asepsis for Preoperative Reduction Of Tracheal Bacterial Establishment, Colonization, and Transmission

Postoperative respiratory complications, such as bacterial pneumonia, are common and serious problems after general anesthesia. They can lead to longer hospital stays, more complications, and increased mortality. One possible cause is that bacteria from the mouth and throat enter the lower airways during tracheal intubation.

The mouth and throat naturally contain many bacteria, including potentially harmful microorganisms. During general anesthesia, coughing and swallowing reflexes are reduced or absent. When a tracheal tube is inserted, secretions from the mouth and throat may be carried into the trachea. The tube may also support the movement of contaminated fluid into the lower airways.

ORAL-PROTECT I is a prospective, randomized, controlled study. It investigates whether simple oral hygiene before surgery can reduce the transfer of bacteria into the trachea during airway management under general anesthesia.

The study includes patients aged 60 years or older undergoing elective surgery under general anesthesia with tracheal intubation. Participants are randomly assigned to an intervention group or a control group. The intervention group performs oral hygiene immediately before anesthesia. This includes brushing the teeth and tongue for about 3 minutes, followed by rinsing and gargling for about 1 minute with a chlorhexidine antiseptic solution. The control group receives standard care without additional oral hygiene.

Oral, pharyngeal, and tracheal swabs will be collected at predefined time points. The primary outcome is based on the perioperative tracheal bacterial load, sampled every 30 minutes and assessed at two hours after induction of anesthesia. The co-primary outcome is based on the oral bacterial load immediately before endotracheal intubation.

Secondary outcomes include changes in oral and tracheal bacterial load over time and identification of the microorganisms detected. The study aims to clarify early bacterial transfer during airway management and to evaluate whether a simple preoperative oral hygiene measure can reduce this process.

Panoramica dello studio

Descrizione dettagliata

ORAL-PROTECT I is a prospective, randomized, controlled, unblinded, parallel-group trial investigating whether preoperative oral hygiene can reduce early bacterial transmission from the mouth and throat into the trachea during airway management under general anesthesia.

Postoperative respiratory complications, including bacterial pneumonia, are common and clinically relevant adverse events after general anesthesia. They can contribute to increased morbidity, prolonged hospital stay, and mortality. One possible mechanism is the transmission of bacteria from the oral cavity and pharynx into the lower airways during tracheal intubation. The oral cavity and pharynx naturally contain a broad bacterial flora, including potentially pathogenic microorganisms. During general anesthesia, protective swallowing and coughing reflexes are reduced or absent. During tracheal intubation, bacteria-contaminated secretions from the mouth and throat may enter the trachea and lower airways.

The study includes patients aged 60 years or older undergoing elective surgery under general anesthesia with tracheal intubation. Potentially eligible patients are screened before surgery. Patients are screened for eligibility during pre-admission testing and are approached for study participation. On the day of surgery, patients are reassessed for eligibility before randomization to confirm that eligibility criteria are still met. Patients who performed oral hygiene less than four hours before induction are excluded before randomization.

Eligible participants are randomly assigned to either the intervention group or the control group using a REDCap-based randomization tool. Participants in the intervention group undergo supervised oral hygiene immediately before induction of anesthesia, consisting of 3 minutes of tongue and tooth brushing and 1 minute of chlorhexidine gargling. Participants in the control group receive standard clinical care without additional preoperative oral hygiene measures. All other perioperative procedures, including anesthetic management, airway management, surgical care, and postoperative treatment, are at the discretion of the treating anesthesiologist and independent of study participation.

Bacterial load is assessed using swab-based microbiological sampling at predefined time points. Samples are collected from the oral cavity, pharynx, and trachea to describe perioperative bacterial contamination and its development over time. The perioperative tracheal bacterial load is sampled at 30-minute intervals.

Sample handling and microbiological processing follow a standardized operating procedure. This includes uniform transport conditions, timely laboratory processing, neutralization of residual antiseptic activity, serial dilution, plating on appropriate culture media, aerobic incubation, and quantitative colony counting. Samples from both study groups are processed identically to minimize systematic bias and allow reliable comparison of bacterial load. Additional assessments include the intraoperative course of tracheal bacterial load, tracheal bacterial load before extubation, oral bacterial load approximately 24 hours after surgery, and qualitative microbiological characterization of detected bacteria. Adverse events are evaluated after the intervention and anesthesia.

The study aims to provide insight into early perioperative bacterial transmission during airway management and to evaluate whether a simple, low-risk preoperative oral hygiene intervention can influence bacterial contamination of the trachea under general anesthesia.

Tipo di studio

Interventistico

Iscrizione (Stimato)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

  • Nome: Physician on Duty
  • Numero di telefono: +49-731-50060043

Luoghi di studio

    • Baden-Wurttemberg
      • Ulm, Baden-Wurttemberg, Germania, 89081
        • Ulm University Medical Center, Department of Anesthesiology and Intensive Care Medicine
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Age ≥ 60 years
  • Elective surgery under general anesthesia with endotracheal intubation
  • Expected duration of surgery ≥ 2 hours
  • Ability to provide written informed consent

Exclusion Criteria:

  • Systemic antibiotic therapy within 7 days before surgery
  • Planned postoperative systemic antibiotic therapy
  • Known hypersensitivity or allergy to chlorhexidine
  • Pneumonia or clinically relevant respiratory infection within 7 days before surgery
  • Inability to perform the study intervention as intended
  • Preoperative oral hygiene on the day of surgery, less than four hours prior to induction of the general anesthesia

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: Standard of care
Standard clinical care without additional preoperative oral hygiene or oral decontamination measures before induction of general anesthesia.
Comparatore attivo: Preoperative oral decontamination with chlorhexidine & tooth & tongue brushing
Supervised preoperative oral decontamination immediately before induction of general anesthesia using chlorhexidine for 1 minute & tooth/tongue brushing for 3 minutes
The intervention consists of supervised preoperative oral decontamination performed in the operating room holding/ induction area immediately before induction of general anesthesia. Participants brush their teeth and tongue for 3 minutes, followed by a rinse with chlorhexidine oral antiseptic solution for 1 minute. The intervention is performed right before endotracheal intubation. All other perioperative procedures are at the discretion of the anesthesiologist in the room.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in tracheal bacterial load at 2 hours after anesthesia induction
Lasso di tempo: At 2 hours after induction and intubation
The primary outcome is the change in tracheal bacterial load, defined through tracheal swab obtained 2 hours after induction of anesthesia.
At 2 hours after induction and intubation
Change in oral bacterial load
Lasso di tempo: Immediately before endotracheal intubation.
The co-primary outcome is the peri-interventional change in oral bacterial load due to the oral hygiene measures obtained through oral swabs immediately before endotracheal intubation.
Immediately before endotracheal intubation.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Intraoperative development of tracheal bacterial load
Lasso di tempo: Every 30 minutes intraoperatively from endotracheal intubation until washout of anesthesia prior to extubation.
This secondary outcome assesses the intraoperative development of tracheal bacterial load during the surgery. Serial tracheal samples are collected every 30 minutes until extubation.
Every 30 minutes intraoperatively from endotracheal intubation until washout of anesthesia prior to extubation.
Change of tracheal bacterial load immediately before extubation
Lasso di tempo: Immediately before extubation.
This secondary outcome assesses the tracheal bacterial load immediately before extubation.
Immediately before extubation.
Change of oral bacterial load 24 hours postoperatively
Lasso di tempo: Approximately 24 hours postoperatively, with a tolerance of ±2 hours.
This secondary outcome assesses the change in oral bacterial load obtained 24 (± 2) hours after surgery.
Approximately 24 hours postoperatively, with a tolerance of ±2 hours.
Qualitative microbiological characterization of bacteria detected in tracheal samples
Lasso di tempo: Tracheal swabs are obtained from right after intubation until extubation. For the primary outcome all samples are plated. If Colony Forming Units (CFU) occur on those within 48 hours, characterization will be performed.
Descriptive analysis of colony forming bacteria that were obtained through tracheal swabs.
Tracheal swabs are obtained from right after intubation until extubation. For the primary outcome all samples are plated. If Colony Forming Units (CFU) occur on those within 48 hours, characterization will be performed.
Safety events related to the oral hygiene intervention
Lasso di tempo: From the start of the oral hygiene intervention until approximately 24 hours postoperatively.
This secondary outcome assesses safety events potentially related to the preoperative oral hygiene intervention, including oral mucosal irritation, discomfort, intolerance of the mouth rinse, or other adverse events.
From the start of the oral hygiene intervention until approximately 24 hours postoperatively.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

20 giugno 2026

Completamento primario (Stimato)

30 ottobre 2026

Completamento dello studio (Stimato)

1 maggio 2027

Date di iscrizione allo studio

Primo inviato

27 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

21 giugno 2026

Primo Inserito (Effettivo)

25 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

25 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

21 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Ethical Committee Number 23/26

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi